Pharm Week 2 Flashcards

1
Q

Describe the three phases of drug activity: (think pharmaceuticals)

A
  1. Pharmaceutical
  2. Pharmacokinetic
  3. Pharmacodynamics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the physiochemical processes mediating drug
action.

A

Describe the physiochemical processes mediating drug
action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain the client variables that influence the rate and extent of Absorption, Distribution, Metabolism,
and Elimination.

A

Absorption, Distribution, Metabolism,
and Elimination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Definitions! Chemical/Generic/Trade name

A

Definitions! Chemical/Generic/Trade name

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

drug actions: (recept the enzyme or be nonspecific)

A
  • drug receptor interaction
  • drug-enzyme interaction
  • nonspecific drug interaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

drug-enzyme interaction

A

drug-enzyme interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

nonspecific drug interaction

A

nonspecific drug interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmaceutical - Dosage form determines the rate (not absorption, but close)

A

drug dissolution (dissolving of solid dosage forms and their absorption from the GI tract). goes from solid and breaks down in gut
🞑 Enteric-coated tablets
🞑 Extended-release form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacokinetic

A

Pharmacokinetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacokinetic (body kinetetics changes a drug)

A

The study of what the body does to the drug
- Absorption
- Distribution
- Metabolism
-Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • drug receptor interaction
A
  • drug receptor interaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Absorption (absorb the bupe into your bloodstream to your sore muscles)

A

the movement from administration into the bloodstream for distribution to the tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Distribution

A

Distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metabolism,

A

Metabolism,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

elimination

A

elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Use Nursing Assessments to identify unusual
and adverse effects of drug therapy.

A

Use Nursing Assessments to identify unusual
and adverse effects of drug therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drugs do not confer any new functions on a
tissue or organ in the body; they only

A

modify
existing functions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Drugs in general exert multiple actions rather
than

A

a single effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Drug action results from a physiochemical
interaction between the (just the drug and a specific molecule - makes sense)

A

drug and a
functionally important molecule in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pharmaceutics (the suits control the dosage and how it affects the body)

A

the study of how various dosage forms influence the way in which the drug affects the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pharmacodynamics involves..(the drug and receptor are dynamic)

A

drug-receptor relationship.
the mechanism of drug actions in living tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pharmacokinetics is the study of what the…(kinetics is a rush) WHICH includes AD ME

A

body does to the drug.
- Absorption
- Distribution
- Metabolism
-Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

pharmaceutics -Dosage form determines the rate of (not absorption, but close)

A

drug dissolution (dissolving of solid dosage forms and their absorption from the GI tract).

Enteric-coated tablets
🞑 Extended-release forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

pharmokinetics (kinetics is down with O/P/D)

A

A drug’s time to Onset of action, time
to Peak effect, and Duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
pharmokinetics is the study of what happens to a drug from the time it is put into the body until the (parents are kin)
the parent drug and all metabolites have left the body
26
pharmacokinetics: absorption - (absoption goes from admin to bloodstream)
Movement of a drug from its site of administration into the bloodstream for distribution to the bioavailability and first pass
27
absorption (compare theabsportionw/onsetandduration)
A comparison of drug Onsets and Duration of Action by Route of Administration. Fastest is IV - bypasses the liver.
28
A drug’s route of administration affects the (and types of routes - PET the route)absorption????
the rate and extent of Absorption of that drug 🞑 Enteral (GI tract) 🞑 Parenteral 🞑 Topical
29
enteral routes
The drug is absorbed into the systemic circulation through the oral or gastric mucosa or the small intestine
30
examples of enteral routes (enteral BROS)
- Oral - Sublingual -Buccal -Rectal (can also be topical)
31
types of parenteral routes (VAAT D MC)
Intravenous (fastest delivery into the blood circulation) Intramuscular Subcutaneous (insulin) Intradermal Intraarterial Intrathecal (in spinal column) Intraarticular (into joint)
32
topical route (LEEN RVS are topical) start with skin, then top of head - eyes, etc.)
 Skin (including transdermal patches)  Eyes  Ears  Nose  Lungs (inhalation)  Rectum  Vagina
33
distribution (distribute from the blood to the worksite)
The transport of a drug by the bloodstream to its site of action
34
types of distribution (distribute the protein, water, and bbb)
 Protein-binding  Water-soluble vs. Fat-soluble  Blood-brain barrier
35
distribution - Areas of rapid distribution - the basic organs (HLK B rapid)
Heart, Liver, Kidneys, Brain (if you are in trauma, body will wall off heart, lungs and brain - most important)
36
distribution - Areas of slow distribution (MS F is slow)
Muscle, Skin, Fat
37
Distribution - A loading dose is administered to...
reach a therapeutic response level rapidly. Maintenance doses are administered at prescribed intervals to maintain a therapeutic drug response.
38
distribution - Maintenance doses are administered at
prescribed intervals to maintain a therapeutic drug response.
39
metabolism/biotransformation (transform into active)
*The biochemical alteration of a drug into an inactive metabolite, a more soluble compound, a more potent active metabolite, or a less active metabolite
40
organs involved in metabolism/biotransformation (I'LL SKP biotransformation)
 Liver (main organ)  Skeletal muscle  Kidneys  Lungs  Plasma  Intestinal mucosa
41
Factors that decrease metabolism (metabolism goes down when my heart and kidneys are starving. Also when I'm yellow from acetylate or ketoconazale)
 Cardiovascular dysfunction  Renal insufficiency  Starvation  Obstructive jaundice-Yellow skin, eyes,, Liver CA, blocked Bile (also overdose of asprin)  Slow acetylator-Liver can’t detoxify becomes toxic  Ketoconazole therapy- tx for fungus or yeast infections
42
Factors that increase metabolism (metabolism goes up during BAR PH (ight)
already outlined
43
excretion is (excrete that drug)
The elimination of drugs from the body
44
organs involved in excretion (excretion is BBBLEK (bleak) (don't need to know all of this)
 Kidneys (main organ)  Liver  Bowel 🞑 Biliary excretion 🞑 Enterohepatic recirculation Biliary recycling
45
half life
 The time it takes for one half of the original amount of a drug to be removed from the body...  A measure of the rate at which a drug is removed from the body  Most drugs considered to be effectively removed after about five half-lives  Steady state- constant drug level- 2, 4, 5X 1/2L
46
bioavailability Refers to the (my percent in bio met the target)
percentage of active drug substances absorbed and available to reach the target tissues following drug administration
47
Drug actions (the actions just occur on a cellular level)
The cellular processes involved in the drug and cell interaction
48
Drug effect (chiva effect is OD or O/P/D)
 The physiologic reaction of the body to the drug  Includes onset, peak, and duration of action
49
Onset (onset is therapeutic)
The time it takes for the drug to elicit a therapeutic response
50
Peak (the peak is the max)
The time it takes for a drug to reach its maximum therapeutic response
51
Duration (duration is therapy)
The time a drug concentration is sufficient to elicit a therapeutic response
52
therapeutic drug monitoring - Peak level
Highest blood level
53
therapeutic drug monitoring - lowest blood level (the trough is low)
Trough level
54
Pharmacotherapeutics / Pharmaceutics Therapeutic index represents the**Need to know for test) (theaputic is lethal)
ratio between two factors: ▪Lethal dose (LD50) ▪Effective dose (ED50) TI = LD50/ED50
55
drugs w/ a narrow therapeutic index (PLAD VW is very narrow)***Know for TEST (amen w/ dog drooling over phentanyl at war w/ valerie)
1. Aminoglycosides (Gentamicin®) 2. Digoxin (Lanoxin®) 3. Lithium (Lithobid®) 4. Phenytoin (Dilantin®) 5. Valproic Acid (Depakote®) 6. Warfarin (Coumadin®)
56
Pharmacodynamics: Mechanisms of Action (REN took action)
 Receptor interactions-  Enzyme interactions-  Nonselective interaction-
57
Receptor interactions- (receptors are on the surface and inside)
reactive site on cell surface or inside cell
58
Enzyme interactions-
catalyst most biochemical rx in cell
59
Enzyme interactions-
catalyst most biochemical rx in cell
60
Nonselective interaction (just doesn't do the other 2 things)
No Rx with receptors or enzymes.
61
drug-receptor interactions - agonist
drug binds to the receptor; there is a response
62
drug-receptor interactions - partial agonist
drug binds to the receptor; the response is diminished compared to agonist
63
drug-receptor interactions - antagonist
drug binds to the receptor: there is no response. drug prevents biding of agonists.
64
drug-receptor interactions - competitive antagonist
drug competes w/ agonist for binding to the receptor: if binds, there is no response.
65
drug-receptor interactions - non-competitive antagonist
drug combines with different parts of the receptor and inactivates it; agonist then has no effect.
66
agonists (mimic the agonist)
• Mimics action of the receptor • A drug that has high affinity and intrinsic activity-(ability of drug to be bound to receptor)
67
antagonist
• Blocks action of the receptor • Acts to prevent receptor activation by endogenous(internal origin) regulatory molecules and agonist drugs
68
Pharmacotherapeutics: Types of Therapies - ON TEST (MSS PPE therapy)
 Maintenance therapy  Supplemental/replacement therapy  Palliative therapy  Supportive therapy  Prophylactic therapy  Empiric therapy
69
contraindications
 Any characteristic of the patient, especially a disease state, that makes the use of a given medication dangerous for the patient  It is important to assess for contraindications! (ex. pregnant women can't take tylenol)
70
monitoring - must be familiar with what?
 Evaluating the clinical response of the patient to the treatment  One must be familiar with the drug’s: • Intended therapeutic action (beneficial) • Unintended but potential adverse effects (predictable, adverse drug reactions)
71
monitoring 2
 Therapeutic index- ratio TI=LD50/ED50  Drug concentration  Patient’s condition-infection/CV/GI/Stress/ depression/anxiety  Tolerance and dependence-I is physiological or psychological response to repeated doses  Drug interactions (additive effect, synergistic effect, antagonistic effect, incompatibility)- action of one drug by another  Adverse drug events- ( Additive effect= 1+1=2, Synergistic effect= 1+1>2, Antagonistic effect= 1+1 < 2 , Incompatible effect= Chemical deteriorated & precipitates )
72
monitoring 3
Adverse drug reactions  Pharmacologic reactions, including adverse effects- (drug too effective dec BP)  Hypersensitivity (allergic) reaction Pt immune sys, histamines cytokines- rash- airway  Idiosyncratic reaction- unexpected rx  Drug interaction- 2 or more drugs together in body cause unusual effect
73
other drug related effects (TMC is all genic)
Teratogenic Mutagenic Carcinogenic
74
drug effects (SAAD side effects)
• Side Effects • Adverse Effects • Allergic Effects • Drug Induced Reaction
75
 Side effects are usually
predictable secondary effects such as anorexia, nausea, vomiting, dizziness, drowsiness, dry mouth, abdominal gas or distress, constipation, and diarrhea.
76
adverse effects are
unintended, undesirable, and often unpredictable drug effects that range from mild to fatal.
77
Drug-Induced Reactions
Drug-Induced Reactions: (you have these definitions in your cards)  Tolerance  Tachyphylaxis  Cumulative effect  Idiosyncrasy  Drug dependence  Drug interaction  Drug antagonism  Summation  Synergism  Potentiation
78
cultural assessment
 Languages spoken  Health beliefs and practices  Past uses of medicine  Herbal treatments, folk remedies, home remedies  Over-the-counter drugs and treatment
79
cultural assessment 2
 Usual response to illness  Responsiveness to medical treatment  Religious practices and beliefs  Support from the patient’s cultural community  Dietary habits
80
legal nursing considerations
 State and federal legislation- FDA, DEA, CA Board of Nursing, DPH  Nurse practice acts oScope of nursing practice- oExpanded nursing roles oEducational requirements oStandards of care oMinimally safe nursing practice oDifferences between nursing and medical practice (Nursing= Caring Medical= Curing) Only MD, APN, NP, OD, Dentist, Podiatrist can prescribe Drugs.
81
legal nursing considerations 2
 Guidelines from professional nursing groups  Institutional policies and procedures, state and federal hospital licensing  Case law or common law- relies on records of similar situations/status d/t no official legal code to apply to the case.  HIPAA- Privacy Lay for Healthcare records
82
ethical considerations
 American Nurses Association (ANA) - Code of Ethics for Nurses- www.nursingworld.org  International Council of Nurses (ICN) - Code of Ethics for Nurses  Duty  Breach of Duty  Causation  Damage ( Book, page 58, 8th ed.)
83
Tachyphylaxis
refers to a quickly developing tolerance that occurs after repeated administration of a drug. (NTG in chest pain)
84
Cumulative effect
occurs when the body cannot metabolize one dose of a drug before another dose is administered. (1+1 = 1.5)
85
Summation (addition or additive effect) occurs when (the sum, 1 + 1 = 2)
the combined effect of two drugs produces a result that equals the sum of the individual effects of each agent. (1+1 =2)
86
Tolerance refers to a
decreased physiologic response that occurs after repeated administration of a drug or a chemically related substance
87
Drug Dependence is the (can be both)
term preferred over the previous terminology of "habituation" and "addiction" can be physical or psychological
88
Synergism describes a
drug interaction in which the combined effect of drugs is greater than the sum of each individual agent acting independently. (1+1 =3)
89
Idiosyncrasy is (Ritalin)
any abnormal of peculiar response to a drug which may manifest by itself by (benadryl makes a kid hyper) 1)over response or abnormal susceptibility to a drug 2) under response, which demonstrates abnormal tolerance 3) a qualitatively different effect from the one expected, such as excitation after the administration of a sedative 4) unpredictable and unexplainable symptoms. often from genetic enzymatic deficiencies
90
Potentiation refers to
the concurrent administration of two drugs in which one drug increases the effect of the other drug. (PI booster in HIV therapy)
91
Which of the following describes the process of the movement of drug molecules from the site of entry into the body?
absorption
92
drugs do not confer
anything
93
critical care
what is white count, infection. Bambis are baby warriors. (band shift)
94
remove old patch and
add new patch to a new area
95
cardivascular decreases...
metabolism.
96
will be on test
The nurse is giving a medication that has a high first-pass effect. The physician has changed the route from IV to PO. The nurse expects the oral dose to most likely be: 1. higher because of the first-pass effect. 2. lower because of the first-pass effect. 3. the same as the IV dose. 4. unchanged.
97
Pharmacotherapeutics: ON TEST Types of Therapies  Acute therapy- CC  Maintenance therapy- Prevent progression of disease, tx;HTN, BC  Supplemental/replacement therapy- replace substance needed, tx; Insulin, thyroid  Palliative therapy- EOL, C/care  Supportive therapy-recovery post Op or trauma, bld after surgery  Prophylactic therapy- prevent illness, vaccines  Empiric therapy- clinical problem- ex: antibx for sepsis
Pharmacotherapeutics: Types of Therapies  Acute therapy- CC  Maintenance therapy- Prevent progression of disease, tx;HTN, BC  Supplemental/replacement therapy- replace substance needed, tx; Insulin, thyroid  Palliative therapy- EOL, C/care  Supportive therapy-recovery post Op or trauma, bld after surgery  Prophylactic therapy- prevent illness, vaccines  Empiric therapy- clinical problem- ex: antibx for sepsis
98
Drug polymorphism - ON TEST
various drug resistance d/t pt age, gender, size, body composition
99
Barriers to adequate health care for culturally diverse-
Language, poverty, access, pride, belief in medicine, need for Cultural Assessment
100
Cultural Assessment
 Languages spoken  Health beliefs and practices  Past uses of medicine  Herbal treatments, folk remedies, home remedies  Over-the-counter drugs and treatment
101
Cultural Assessment - 2
Cultural Assessment  Usual response to illness  Responsiveness to medical treatment  Religious practices and beliefs  Support from the patient’s cultural community  Dietary habits
102
Legal Nursing Considerations
 Guidelines from professional nursing groups  Institutional policies and procedures, state and federal hospital licensing  Case law or common law- relies on records of similar situations/status d/t no official legal code to apply to the case.  HIPAA- Privacy Lay for Healthcare records
103
Ethical Considerations
 American Nurses Association (ANA) - Code of Ethics for Nurses- www.nursingworld.org  International Council of Nurses (ICN) - Code of Ethics for Nurses  Duty  Breach of Duty  Causation  Damage ( Book, page 58, 8th ed.)
104
absorption involves...(absoption is available at first pass)
🞑 Bioavailability 🞑 First-pass effect (liver says gimme first, then everything else goes into circulatory)
105
- Fast acetylator - decrease or increase metabolism?
increase
106
- Barbiturate therapy CNS depressant, Tx Sz, Anesthesia - increase or decrease metabolism?
increase metabolism
107
- Rifampin therapy- TB meds. - Phenytoin therapy- Sz - seizures - increase or decrease metabolism?
-increase
108
MH - hypothermia - increase or decrease metabolism?
increase. - their bodies react - code MH - have to have meds or their temp goes up one degree a minute. Then they get lock jaw.
109
Affinity (seen with agonists)
promotes binding (level of degree drug attaches or binds with receptor)
110
• Intrinsic Activity (seen w/ agonists)
allows the bound agonist to activate the receptor
111
antagonist - what's the deal w/ affinity and intrinsic activity
• High affinity but no intrinsic activity
112
pharamacotherauptic - Maintenance therapy
Prevent progression of disease, tx;HTN, BC
113
 Supplemental/replacement therapy
replace substance needed, tx;Insulin, thyroid
114
 Palliative therapy
EOL, C/care
115
 Supportive therapy(postop)
recovery post Op or trauma, bld after surgery
116
 Prophylactic therapy
prevent illness, vaccines
117
 Empiric therapy(clinical problem)
clinical problem- ex: antibx for sepsis (like broadspectrum antibiotics)
118
drug related effects - Teratogenic
Structural defects to Fetus
119
drug related effects - Mutagenic
Permanent change to genetic DNA: Radiation/virus/chemicals
120
drug related effects - Carcinogenic
Cancer causing
121
pharamacokenetics
the branch of pharmacology concerned with the movement of drugs within the body
122
metabolism/biotransformation involves what organs or systems? (I'LL SKP biotransformation)
 Liver (main organ)  Skeletal muscle  Kidneys  Lungs  Plasma  Intestinal mucosa
123
pharmacotherapeutics focuses on (therapy - it's in the name)
clinical use of drugs and how to prevent and treat diseases.
124
can granules be crushed?
no
125
remember, inhalers are what form of ingestion?
topical
126
parents are kin
pharmacokinetics - what happens to the drug between the time of administration until the parent drug and all of its metabolites have left the body
127
first pass
if a large amount of drug is absorbed by liver, less amount will be circulated.
128
high first pass rate
a large amount of drug is absorbed by liver and less will reach target sites
129
first pass reduces what?
the bioavailability
130
how bioavailable are IV drugs?
100%, because none is absorbed by the liver
131
what changes absorption of drug after it leaves the liver?
stomach acid, food or water or no food or water, changes in intestines
132
short bowel syndrome
stomach contents are delivered to intestines more rapidly, resulting in gastric dumping